Prelude Therapeutics Inc (PRLD)

10:05 AM

Incyte (INCY) Secures $935M Deal with Prelude Therapeutics for J - GuruFocus

10:05 AM

10:02 AM

Major Shift in PRLD Stock: What’s Behind the Surge?​ - StocksToTrade

10:02 AM

09:56 AM

Prelude Therapeutics (PRLD) Stock’s Wild Ride: 150% Surge, Big Pharma Deal & What’s Next - ts2.tech

09:56 AM

09:53 AM

Dow Dips Over 400 Points; Pfizer Earnings Top Estimates - Benzinga

09:53 AM

09:40 AM

Prelude loses CMO, pauses SMARCA2 degraders and bags $60M from Incyte - Fierce Biotech

09:40 AM

09:26 AM

Incyte inks option agreement with Prelude for JH2 inhibitor program - Seeking Alpha

09:26 AM

09:21 AM

Prelude Therapeutics Signs Option Agreement with Incyte - TipRanks

09:21 AM

09:19 AM

Prelude Therapeutics’ Stock Performance: Rise or Risk? - timothysykes.com

09:19 AM

09:06 AM

Why Is Prelude Therapeutics Stock (PRLD) Down 45% Today? - TipRanks

09:06 AM

09:01 AM

Prelude Therapeutics pauses clinical development of SMARCA2 degrader program (PRLD:NASDAQ) - Seeking Alpha

09:01 AM

08:55 AM

Prelude Therapeutics Announces Management Changes - TradingView

08:55 AM

08:36 AM

Prelude to prioritize JAK2V617F JH2 inhibitor, KAT6A selective degrader programs - TipRanks

08:36 AM

08:29 AM

Prelude Therapeutics CMO Jane Huang departs - TipRanks

08:29 AM

08:11 AM

PRLD's Financial Outlook: Cash Runway Extended to 2027 - GuruFocus

08:11 AM

08:07 AM

Incyte (INCY) Secures Option for JAK2V617F Program in $910M Deal - GuruFocus

08:07 AM

08:07 AM

Incyte (INCY) Secures Exclusive Option on JAK2V617F Program - GuruFocus

08:07 AM

07:41 AM

Prelude Therapeutics sees cash runway into 2027 - TipRanks

07:41 AM

07:38 AM

Prelude Therapeutics pauses development of SMARCA2 degrader program - TipRanks

07:38 AM

07:38 AM

Prelude Therapeutics stock climbs after exclusive JAK2 option deal with Incyte - Investing.com Nigeria

07:38 AM

07:34 AM

Prelude Therapeutics shifts focus to JAK2 and KAT6A programs - Investing.com

07:34 AM

07:16 AM

A Look at Prelude Therapeutics Inc (PRLD) Shares in the Recent Past Indicates Growth - setenews.com

07:16 AM

07:15 AM

Incyte Enters Exclusive Option Agreement to Acquire Prelude Therapeutics' JAK2V617F Inhibitor Program for MPNs - Quiver Quantitative

07:15 AM

07:05 AM

Prelude Therapeutics Announces Strategic Business Update - GlobeNewswire

07:05 AM

07:01 AM

Prelude (NASDAQ: PRLD) grants Incyte option on JAK2V617F; $60M, $100M on exercise - Stock Titan

07:01 AM

06:39 AM

Is Prelude Therapeutics Incorporated stock supported by innovation pipelineJuly 2025 Snapshot & Weekly Watchlist for Hot Stocks - newser.com

06:39 AM

06:22 AM

Here's Why Prelude Therapeutics (NASDAQ:PRLD) Must Use Its Cash Wisely - 富途牛牛

06:22 AM

06:10 AM

Can Prelude Therapeutics Incorporated stock sustain free cash flow growth2025 Price Targets & AI Enhanced Trading Signals - newser.com

06:10 AM

05:34 AM

Can Prelude Therapeutics Incorporated stock hit analyst price targetsMarket Weekly Review & Safe Capital Growth Tips - newser.com

05:34 AM

04:23 AM

Will Prelude Therapeutics Incorporated stock deliver shareholder valueSwing Trade & Safe Investment Capital Preservation Plans - newser.com

04:23 AM

03:33 AM

What institutional flow reveals about Prelude Therapeutics IncorporatedMarket Sentiment Report & Free Low Drawdown Momentum Trade Ideas - newser.com

03:33 AM

02:45 AM

Prelude Therapeutics (PRLD) Projected to Post Earnings on Wednesday - Defense World

02:45 AM

02:24 AM

Prelude Therapeutics Spikes: Can The Pipeline Keep Up? - RTTNews

02:24 AM

01:35 AM

Prelude Therapeutics (NASDAQ:PRLD) and CytoDyn (OTCMKTS:CYDY) Financial Analysis - Defense World

01:35 AM

Nov 03, 2025

Prelude Therapeutics: A Subtle Shift In Pipeline Underscores Funding Challenges - Seeking Alpha

Nov 03, 2025

Nov 03, 2025

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.51% - Investing.com

Nov 03, 2025

Nov 03, 2025

Prelude Therapeutics (PRLD) to Present Preclinical Findings at A - GuruFocus

Nov 03, 2025

Nov 03, 2025

Prelude Therapeutics announces publication of abstracts for ASH meeting - TipRanks

Nov 03, 2025

Nov 03, 2025

Is Prelude Therapeutics Incorporated stock ready for a breakoutQuarterly Trade Review & High Accuracy Trade Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Prelude Therapeutics Announces Publication of Abstracts for - GlobeNewswire

Nov 03, 2025

Nov 03, 2025

Pattern recognition hints at Prelude Therapeutics Incorporated upsideJuly 2025 Market Mood & Stepwise Swing Trade Plans - newser.com

Nov 03, 2025

Nov 03, 2025

What to do if you’re stuck in Prelude Therapeutics IncorporatedJuly 2025 Weekly Recap & Safe Swing Trade Setups - newser.com

Nov 03, 2025

Nov 03, 2025

Is Prelude Therapeutics Incorporated stock a defensive play in 2025Bond Market & Real-Time Market Sentiment Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

How Prelude Therapeutics Incorporated stock reacts to oil pricesJuly 2025 Movers & High Accuracy Swing Entry Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Volume spikes in Prelude Therapeutics Incorporated stock – what they meanJuly 2025 Recap & Technical Pattern Based Buy Signals - newser.com

Nov 03, 2025

Nov 02, 2025

Can Prelude Therapeutics Incorporated stock maintain operating marginsJuly 2025 Snapshot & Consistent Income Trade Recommendations - newser.com

Nov 02, 2025

Nov 02, 2025

Is Prelude Therapeutics Incorporated stock supported by strong fundamentalsPortfolio Performance Report & High Return Trade Guides - newser.com

Nov 02, 2025

Nov 02, 2025

Prelude Therapeutics Shares Surge on Analyst Optimism and Upcoming Earnings - AD HOC NEWS

Nov 02, 2025

Nov 02, 2025

Prelude Therapeutics Incorporat (PRLD) stock forecast and price target - Yahoo! Finance UK

Nov 02, 2025

Nov 02, 2025

What sentiment indicators say about Prelude Therapeutics Incorporated stockWatch List & Verified Technical Trade Signals - newser.com

Nov 02, 2025

Nov 02, 2025

Using flow based indicators on Prelude Therapeutics IncorporatedDip Buying & Safe Entry Zone Tips - newser.com

Nov 02, 2025

Nov 01, 2025

How to build a custom watchlist for Prelude Therapeutics Incorporated2025 Investor Takeaways & Weekly Momentum Picks - newser.com

Nov 01, 2025